CK5 protein marks ovarian cancer likely to be resistant to cisplatin

[News]

A University of Colorado Cancer Center study recently published in the International Journal of Gynecological Cancer shows that protein cytokeratin 5 (CK5), known to be a marker of poor prognosis in breast cancer, also marks ovarian cancers likely to be resistant to the common chemotherapy cisplatin.

More... (http://www.news-medical.net/news/20151105/CK5-protein-marks-ovarian-cancer-likely-to-be-resistant-to-cisplatin.aspx)